Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

Similar articles for PubMed (Select 20356410)

1.

Maternal inheritance and mitochondrial DNA variants in familial Parkinson's disease.

Simon DK, Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Nichols WC, Foroud T; Parkinson Study Group-PROGENI Investigators.

BMC Med Genet. 2010 Apr 1;11:53. doi: 10.1186/1471-2350-11-53.

2.

Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population.

Huerta C, Castro MG, Coto E, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, Martínez C, Lahoz CH, Alvarez V.

J Neurol Sci. 2005 Sep 15;236(1-2):49-54.

PMID:
15975594
3.

Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians.

Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, Barone P, Pellecchia MT, Stanzione P, Brusa L, Bentivoglio AR, Bonuccelli U, Petrozzi L, Abbruzzese G, Marchese R, Cortelli P, Grimaldi D, Martinelli P, Ferrarese C, Garavaglia B, Sangiorgi S, Carelli V, Torroni A, Albanese A, Zeviani M.

Eur J Hum Genet. 2005 Jun;13(6):748-52.

4.

Mitochondrial transcription factor A variants and the risk of Parkinson's disease.

Gaweda-Walerych K, Safranow K, Maruszak A, Bialecka M, Klodowska-Duda G, Czyzewski K, Slawek J, Rudzinska M, Styczynska M, Opala G, Drozdzik M, Kurzawski M, Szczudlik A, Canter JA, Barcikowska M, Zekanowski C.

Neurosci Lett. 2010 Jan 18;469(1):24-9. doi: 10.1016/j.neulet.2009.11.037. Epub 2009 Nov 17.

PMID:
19925850
5.

Mitochondrial DNA polymorphisms and the risk of Parkinson's disease in Taiwan.

Chen CM, Kuan CC, Lee-Chen GJ, Wu YR.

J Neural Transm. 2007;114(8):1017-21. Epub 2007 Mar 15.

PMID:
17357825
6.

mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish.

Ross OA, McCormack R, Maxwell LD, Duguid RA, Quinn DJ, Barnett YA, Rea IM, El-Agnaf OM, Gibson JM, Wallace A, Middleton D, Curran MD.

Exp Gerontol. 2003 Apr;38(4):397-405.

PMID:
12670626
7.

PARK2 variability in Polish Parkinson's disease patients--interaction with mitochondrial haplogroups.

Gaweda-Walerych K, Safranow K, Jasinska-Myga B, Bialecka M, Klodowska-Duda G, Rudzinska M, Czyzewski K, Cobb SA, Slawek J, Styczynska M, Opala G, Drozdzik M, Nishioka K, Farrer MJ, Ross OA, Wszolek ZK, Barcikowska M, Zekanowski C.

Parkinsonism Relat Disord. 2012 Jun;18(5):520-4. doi: 10.1016/j.parkreldis.2012.01.021. Epub 2012 Feb 22.

8.

A mitochondrial etiology of neurodegenerative diseases: evidence from Parkinson's disease.

Khusnutdinova E, Gilyazova I, Ruiz-Pesini E, Derbeneva O, Khusainova R, Khidiyatova I, Magzhanov R, Wallace DC.

Ann N Y Acad Sci. 2008 Dec;1147:1-20. doi: 10.1196/annals.1427.001.

PMID:
19076426
9.

Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community.

Mehta P, Mellick GD, Rowe DB, Halliday GM, Jones MM, Manwaring N, Vandebona H, Silburn PA, Wang JJ, Mitchell P, Sue CM.

Mov Disord. 2009 Jan 30;24(2):290-2. doi: 10.1002/mds.22389.

PMID:
19086081
10.

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Van Broeckhoven C, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Ferraris A, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Farrer MJ; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.

Lancet Neurol. 2011 Oct;10(10):898-908. doi: 10.1016/S1474-4422(11)70175-2. Epub 2011 Aug 30. Erratum in: Lancet Neurol. 2011 Oct;10(10):870.

11.

Mitochondrial DNA and TFAM gene variation in early-onset myocardial infarction: evidence for an association to haplogroup H.

Palacín M, Alvarez V, Martín M, Díaz M, Corao AI, Alonso B, Díaz-Molina B, Lozano I, Avanzas P, Morís C, Reguero JR, Rodríguez I, López-Larrea C, Cannata-Andía J, Batalla A, Ruiz-Ortega M, Martínez-Camblor P, Coto E.

Mitochondrion. 2011 Jan;11(1):176-81. doi: 10.1016/j.mito.2010.09.004. Epub 2010 Sep 21.

PMID:
20863902
12.

Mitochondrial DNA polymorphisms as risk factors for Parkinson's disease and Parkinson's disease dementia.

Autere J, Moilanen JS, Finnilä S, Soininen H, Mannermaa A, Hartikainen P, Hallikainen M, Majamaa K.

Hum Genet. 2004 Jun;115(1):29-35. Epub 2004 Apr 24.

PMID:
15108120
13.

Mitochondrial transcription factor A (TFAM) gene variation in Parkinson's disease.

Alvarez V, Corao AI, Sánchez-Ferrero E, De Mena L, Alonso-Montes C, Huerta C, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, García-Castro M, Coto E.

Neurosci Lett. 2008 Feb 13;432(1):79-82. doi: 10.1016/j.neulet.2007.12.010. Epub 2007 Dec 15.

PMID:
18248889
14.

LRRK2 gene in Parkinson disease: mutation analysis and case control association study.

Paisán-Ruíz C, Lang AE, Kawarai T, Sato C, Salehi-Rad S, Fisman GK, Al-Khairallah T, St George-Hyslop P, Singleton A, Rogaeva E.

Neurology. 2005 Sep 13;65(5):696-700.

PMID:
16157901
15.

Mitochondrial DNA polymorphisms and haplogroups in Parkinson's disease and control individuals with a similar genetic background.

Latsoudis H, Spanaki C, Chlouverakis G, Plaitakis A.

J Hum Genet. 2008;53(4):349-56. doi: 10.1007/s10038-008-0259-1. Epub 2008 Feb 20.

PMID:
18286226
16.

Association study of two genetic variants in mitochondrial transcription factor A (TFAM) in Alzheimer's and Parkinson's disease.

Belin AC, Björk BF, Westerlund M, Galter D, Sydow O, Lind C, Pernold K, Rosvall L, Håkansson A, Winblad B, Nissbrandt H, Graff C, Olson L.

Neurosci Lett. 2007 Jun 15;420(3):257-62. Epub 2007 May 10.

PMID:
17537576
17.

Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson's disease risk in a Polish PD cohort.

Gaweda-Walerych K, Maruszak A, Safranow K, Bialecka M, Klodowska-Duda G, Czyzewski K, Slawek J, Rudzinska M, Styczynska M, Opala G, Drozdzik M, Canter JA, Barcikowska M, Zekanowski C.

J Neural Transm. 2008 Nov;115(11):1521-6. doi: 10.1007/s00702-008-0121-9. Epub 2008 Sep 23.

PMID:
18810306
18.

Mitochondrial DNA sequence variation in Finnish patients with matrilineal diabetes mellitus.

Soini HK, Moilanen JS, Finnila S, Majamaa K.

BMC Res Notes. 2012 Jul 10;5:350. doi: 10.1186/1756-0500-5-350.

19.

Mitochondrial DNA haplogroups and mutations in children with acquired central demyelination.

Venkateswaran S, Zheng K, Sacchetti M, Gagne D, Arnold DL, Sadovnick AD, Scherer SW, Banwell B, Bar-Or A, Simon DK; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2011 Mar 1;76(9):774-80. doi: 10.1212/WNL.0b013e31820ee1bb. Epub 2011 Feb 2.

20.

Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease.

van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH Jr, Goetz CG, Small GW, Mastaglia F, Stajich JM, McLaurin AC, Middleton LT, Scott BL, Schmechel DE, Pericak-Vance MA, Vance JM.

Am J Hum Genet. 2003 Apr;72(4):804-11. Epub 2003 Feb 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk